According to ImmunityBio's latest financial reports and stock price the company's current Operating Margin is -147,405.00%. At the end of 2021 the company had an Operating Margin of -37,456.00%.
Year | Operating Margin | Change |
---|---|---|
2021 | -37,456.00% | 0.25% |
2020 | -37,360.83% | 413.33% |
2019 | -7,278.07% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.